Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
Istios Health, a physician-led healthcare technology and services company advancing specialty care delivery through integrated clinical services.
-
Dublin, Jan. 26, 2026 (GLOBE NEWSWIRE) -- The "Dental Composites Market - Global Forecast 2026-2032" has been added to ResearchAndMarkets.com's offering.The Dental Composites Market witnessed...
-
- Cogent will submit the PEAK New Drug Application (NDA) under previously announced RTOR designation; on track to complete NDA submission in April 2026 WALTHAM, Mass. and BOULDER, Colo., Jan. 26,...
-
Dublin, Jan. 23, 2026 (GLOBE NEWSWIRE) -- The "Organ Preservation Solution Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031" has been added to ...
-
Dublin, Jan. 23, 2026 (GLOBE NEWSWIRE) -- The "Veterinary Hospital Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031" has been added to ResearchAndMarkets.com's...
-
Chicago, Jan. 22, 2026 (GLOBE NEWSWIRE) -- According to recent data from Astute Analytica, the global vital signs monitoring devices market was valued at US$ 5,628.7 million in 2024 and is projected...
-
TEL AVIV, Israel, Jan. 22, 2026 (GLOBE NEWSWIRE) -- StuffThatWorks today announced that Julie A. Ross, former CEO of global CRO Advanced Clinical, has joined the company as Chief Executive Officer...
-
Austin, Texas, Jan. 22, 2026 (GLOBE NEWSWIRE) -- Immune Repertoire Sequencing Market Growth Analysis: As per SNS Insider, the Immune Repertoire Sequencing Market was valued at USD 369.93 million in...
-
- PEAK trial first ever study to demonstrate statistical significance over an active comparator in GIST patients, with bezuclastinib plus sunitinib combination demonstrating mPFS of 16.5 months and...
-
Primary Safety Endpoint Demonstrated to Date; Top-Line Efficacy Data Expected in Q3 2026 Ramat Gan, Israel, Jan. 20, 2026 (GLOBE NEWSWIRE) -- Can-Fite BioPharma Ltd. (NYSE American: CANF) (TASE:...